NURC
NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
07/07/2026
Back to search
Official data from USPTO
NEUROSTAT
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
42
Latest update
07/07/2026
Trademark type
Word
Nice classes
5
Filing date
02/29/2012
Registration date
06/04/2013
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/14/2023
Last transaction
07/07/2026
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2011-04-00
First use in commerce
2011-04-00
Drawing code
4
Owner type
26
Owner location
LEIDEN, NL
Examiner
LE, KHANH M
Current location
Historical data usage
Holders and representatives
Holders
PHARMING INTELLECTUAL PROPERTY B.V.
ABLIVA AB
NeuroVive Pharmaceutical AB
Representatives
Michael B. Chesal Peretz Chesal & Herrmann, P.L.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for medical use consisting of a cyclosporin as active agent and diluents to treat stroketraumatic brain or spinal cord injuryother acute or chronic neurological and neurosurgical conditions
Publications
History of USPTO decisions and trademark events.
42 publications found
C.7C
NEW CERTIFICATE UNDER SECTION 7 - PROCESSED
06/18/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/11/2026
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
04/01/2026
ES7R
TEAS SECTION 7 REQUEST RECEIVED
03/29/2026
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
11/14/2023
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
11/14/2023
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
11/14/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
11/08/2023
E89R
TEAS SECTION 8 & 9 RECEIVED
05/15/2023
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
04/26/2023
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
06/04/2022
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
12/18/2019
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
12/18/2019
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
12/06/2019
PRA8
POST REGISTRATION ACTION MAILED - SEC. 8
06/14/2019
XXXX
POST REGISTRATION ACTION CORRECTION
06/14/2019
PRA8
POST REGISTRATION ACTION MAILED - SEC. 8
06/13/2019
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/12/2019
ES8R
TEAS SECTION 8 RECEIVED
06/03/2019
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
06/04/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
06/04/2013
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
04/30/2013
REGV
LAW OFFICE REGISTRATION REVIEW COMPLETED
04/27/2013
ALIE
ASSIGNED TO LIE
04/26/2013
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
04/15/2013
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03/29/2013
SUPC
STATEMENT OF USE PROCESSING COMPLETE
03/28/2013
EX1G
SOU EXTENSION 1 GRANTED
03/28/2013
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
03/27/2013
IUAF
USE AMENDMENT FILED
03/11/2013
EXT1
SOU EXTENSION 1 FILED
03/11/2013
EEXT
SOU TEAS EXTENSION RECEIVED
03/11/2013
EISU
TEAS STATEMENT OF USE RECEIVED
03/11/2013
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
09/11/2012
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/17/2012
PUBO
PUBLISHED FOR OPPOSITION
07/17/2012
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/27/2012
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/11/2012
DOCK
ASSIGNED TO EXAMINER
06/11/2012
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/07/2012
NWAP
NEW APPLICATION ENTERED
03/03/2012
Continuous trademark protection
Get notified about every new filing that threatens NEUROSTAT or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.